Skip to main content

Table 1 Clinical and laboratorial parameters of patients with DM2 and DRD with severely increased albuminuria

From: Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease

Clinical features

N = 48

Age (Years)

66 ± 6.7

Sex (M/F)

27/21

BMI (kg/m²)

29.5 ± 3.9

Time of T2DM diagnosis (years)

16.8 ± 8.4

Dyslipidemia (yes %)

47 (91.6)

Hypertension (yes %)

45 (93.7)

Systolic blood pressure (mmHg)

138.6 ± 17.2

Diastolic blood pressure (mmHg)

70.4 ± 8.3

Cardiovascular event (yes %)

5 (10.4)

Peripheral neuropathy (yes %)

37 (77.1)

Ankle brachial index

0.81 ± 0.08

Retinopathy (yes %)

8 (16.6)

Smoking (yes %)

16 (33.3)

Glycemia (mg/dl)

161 ± 61.1

Glycated hemoglobin (%)

8.3 ± 1.3

Creatinine (mg/dL)

1.44 ± 0.41

Clearance (CKD-EPI) (mL/min/1.73 m²)

51.23 ± 13.7

Mean albuminuria (mg/g)

614.00 ± 584.6

Mean albuminuria (log10)

2.56 ± 0.5

Autonomic neuropathy (yes %)

36 (75)

Beta-blockers (yes %)

16 (33%)

ACEI/ARB (yes %)

47 (98%)

  1. Source: Author data.